These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 30076287)

  • 1. A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein.
    Li A; Yu J; Lu M; Ma Y; Attia Z; Shan C; Xue M; Liang X; Craig K; Makadiya N; He JJ; Jennings R; Shi PY; Peeples ME; Liu SL; Boyaka PN; Li J
    Nat Commun; 2018 Aug; 9(1):3067. PubMed ID: 30076287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vesicular Stomatitis Virus and DNA Vaccines Expressing Zika Virus Nonstructural Protein 1 Induce Substantial but Not Sterilizing Protection against Zika Virus Infection.
    Li A; Xue M; Attia Z; Yu J; Lu M; Shan C; Liang X; Gao TZ; Shi PY; Peeples ME; Boyaka PN; Liu SL; Li J
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32554698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NS1-based DNA vaccination confers mouse protective immunity against ZIKV challenge.
    Zhan Y; Pang Z; Du Y; Wang W; Yang Y; Wang W; Gao GF; Huang B; Deng Y; Tan W
    Infect Genet Evol; 2020 Nov; 85():104521. PubMed ID: 32882433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models.
    Guo Q; Chan JF; Poon VK; Wu S; Chan CC; Hou L; Yip CC; Ren C; Cai JP; Zhao M; Zhang AJ; Song X; Chan KH; Wang B; Kok KH; Wen Y; Yuen KY; Chen W
    J Infect Dis; 2018 Jul; 218(3):365-377. PubMed ID: 29617816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models.
    Li P; Ke X; Wang T; Tan Z; Luo D; Miao Y; Sun J; Zhang Y; Liu Y; Hu Q; Xu F; Wang H; Zheng Z
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
    Garg H; Sedano M; Plata G; Punke EB; Joshi A
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined vaccination protocol of DNA/MVA expressing Zika virus structural proteins as efficient inducer of T and B cell immune responses.
    Pérez P; Martín-Acebes MA; Poderoso T; Lázaro-Frías A; Saiz JC; Sorzano CÓS; Esteban M; García-Arriaza J
    Emerg Microbes Infect; 2021 Dec; 10(1):1441-1456. PubMed ID: 34213405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a Species E Adenovirus Vector as a Zika virus vaccine.
    Bullard BL; Corder BN; Gordon DN; Pierson TC; Weaver EA
    Sci Rep; 2020 Feb; 10(1):3613. PubMed ID: 32107394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice.
    Wang R; Liao X; Fan D; Wang L; Song J; Feng K; Li M; Wang P; Chen H; An J
    Vaccine; 2018 Jun; 36(24):3522-3532. PubMed ID: 29753607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine protection against Zika virus from Brazil.
    Larocca RA; Abbink P; Peron JP; Zanotto PM; Iampietro MJ; Badamchi-Zadeh A; Boyd M; Ng'ang'a D; Kirilova M; Nityanandam R; Mercado NB; Li Z; Moseley ET; Bricault CA; Borducchi EN; Giglio PB; Jetton D; Neubauer G; Nkolola JP; Maxfield LF; De La Barrera RA; Jarman RG; Eckels KH; Michael NL; Thomas SJ; Barouch DH
    Nature; 2016 Aug; 536(7617):474-8. PubMed ID: 27355570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inactivated recombinant rabies virus displaying the Zika virus prM-E induces protective immunity against both pathogens.
    Jin H; Jiao C; Cao Z; Huang P; Chi H; Bai Y; Liu D; Wang J; Feng N; Li N; Zhao Y; Wang T; Gao Y; Yang S; Xia X; Wang H
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009484. PubMed ID: 34086672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika Virus in an Allogeneic Mouse Pregnancy Model.
    Nürnberger C; Bodmer BS; Fiedler AH; Gabriel G; Mühlebach MD
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity.
    Zou J; Xie X; Luo H; Shan C; Muruato AE; Weaver SC; Wang T; Shi PY
    EBioMedicine; 2018 Oct; 36():92-102. PubMed ID: 30201444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors.
    López-Camacho C; Abbink P; Larocca RA; Dejnirattisai W; Boyd M; Badamchi-Zadeh A; Wallace ZR; Doig J; Velazquez RS; Neto RDL; Coelho DF; Kim YC; Donald CL; Owsianka A; De Lorenzo G; Kohl A; Gilbert SC; Dorrell L; Mongkolsapaya J; Patel AH; Screaton GR; Barouch DH; Hill AVS; Reyes-Sandoval A
    Nat Commun; 2018 Jun; 9(1):2441. PubMed ID: 29934593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Live-Attenuated Zika Virus Vaccine with High Production Capacity Confers Effective Protection in Neonatal Mice.
    Ye X; Liu X; Shu T; Deng W; Liao M; Zheng Y; Zheng X; Zhang X; Li T; Fan W; Qu L; Chen L; Li F; Feng L
    J Virol; 2021 Jun; 95(14):e0038321. PubMed ID: 33910950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.
    Xu K; Song Y; Dai L; Zhang Y; Lu X; Xie Y; Zhang H; Cheng T; Wang Q; Huang Q; Bi Y; Liu WJ; Liu W; Li X; Qin C; Shi Y; Yan J; Zhou D; Gao GF
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29298885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient Control of Zika Virus Infection Induced by a Non-Replicating Adenovector Encoding Zika Virus NS1/NS2 Antigens Fused to the MHC Class II-Associated Invariant Chain.
    Nazerai L; Buus S; Stryhn A; Thomsen AR; Christensen JP
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Zika virus DNA vaccines based on NS1 and domain III of E.
    Xiong G; Li Y; Chen F; Xiong X; Wang Q; Zhang L; Dong H; Zhu C; Cui J; He M; Cheng H; Hu A; Cheng C; Pang J; Liu G; Chen H
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109308. PubMed ID: 36274487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via Fc
    Yu L; Liu X; Ye X; Su W; Zhang X; Deng W; Luo J; Xiang M; Guo W; Zhang S; Xu W; Yan Q; Wang Q; Cui Y; Wu C; Guo W; Niu X; Zhang F; Lei C; Qu L; Chen L; Feng L
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
    Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
    Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.